These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
149 related items for PubMed ID: 2525013
1. Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacs. Mannucci PM, Zanetti AR, Gringeri A, Tanzi E, Morfini M, Messori A, Tirindelli MC, de Biasi R, Ciavarella N, Colombo M. Arch Intern Med; 1989 Jun; 149(6):1333-7. PubMed ID: 2525013 [Abstract] [Full Text] [Related]
4. Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies. Gandhi RT, Wurcel A, Lee H, McGovern B, Shopis J, Geary M, Sivamurthy R, Sax PE, Ukomadu C. J Infect Dis; 2005 May 01; 191(9):1435-41. PubMed ID: 15809901 [Abstract] [Full Text] [Related]
7. [Efficacy of vaccination against hepatitis B in adult with HIV infection]. Kalinowska-Nowak A, Bociaga-Jasik M, Garlicki A, Mach T. Przegl Epidemiol; 2007 May 01; 61(2):339-47. PubMed ID: 17956052 [Abstract] [Full Text] [Related]
9. Twelve-year follow-up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children. Yuen MF, Lim WL, Cheng CC, Lam SK, Lai CL. Hepatology; 1999 Mar 01; 29(3):924-7. PubMed ID: 10051499 [Abstract] [Full Text] [Related]
14. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy. Samandari T, Fiore AE, Negus S, Williams JL, Kuhnert W, McMahon BJ, Bell BP. Pediatrics; 2007 Aug 01; 120(2):e373-81. PubMed ID: 17636112 [Abstract] [Full Text] [Related]
15. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen. Hsu HY, Chang MH, Hsieh RP, Ni YH, Chi WK. Hepatology; 1996 Dec 01; 24(6):1355-60. PubMed ID: 8938161 [Abstract] [Full Text] [Related]
17. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults. Van Damme P, Leroux-Roels G, Law B, Diaz-Mitoma F, Desombere I, Collard F, Tornieporth N, Van Herck K. J Med Virol; 2001 Sep 01; 65(1):6-13. PubMed ID: 11505437 [Abstract] [Full Text] [Related]
18. Immune response to hepatitis B vaccine in infants and newborns: control trial in an endemic area (Senegal). Coursaget P, Deciron F, Tortey E, Barin F, Chiron JP, Yvonnet B, Diouf C, Denis F, Diop-Mar I, Correa P. IARC Sci Publ; 1984 Sep 01; (63):319-35. PubMed ID: 6242150 [Abstract] [Full Text] [Related]
19. [Long-term efficacy and persistence of Chinese infants after receiving only active plasma-derived hepatitis B vaccine]. Xia G, Jia Z, Yan T, Li R, Liu H, Xu Z, Cao H, Liu C. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Jun 01; 16(2):146-9. PubMed ID: 12196826 [Abstract] [Full Text] [Related]
20. A review of the long-term protection after hepatitis A and B vaccination. Van Damme P, Van Herck K. Travel Med Infect Dis; 2007 Mar 01; 5(2):79-84. PubMed ID: 17298912 [Abstract] [Full Text] [Related] Page: [Next] [New Search]